All Stories

  1. Rosa × damascena Herrm. and Commiphora wightii (Arn.) Bhandari. combination therapy ameliorates cognitive, neurobehavioral and metabolic impairments in a rat model of Alzheimer's disease through restoration of mitochondrial functions, regulation of neu...
  2. Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer’s disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction
  3. Exploring the combined therapeutic potential of Rosa × damascena Herrm. and Commiphora wightii (Arn.) Bhandari. against STZ-induced behavioural deficits and neuropathology in zebrafish model of Alzheimer’s disease
  4. ELUCIDATING THE MULTI-TARGETED EFFECTS OF Z-GUGGULSTERONE IN ALZHEIMER’S DISEASE: INSIGHTS FROM NETWORK PHARMACOLOGY AND MOLECULAR DOCKING
  5. Multimodal therapeutic potential of Reinwardtia indica Dumort. in rodent model of cerebral ischemia: Attenuations of oxidative and neuroinflammatory stress, restoration of neurotransmitter and mitochondrial homeostasis, suppression of apoptotic signali...
  6. Exploring the combined protective effect of Rosa damascena and Commiphora wightii in alleviating aluminum-induced neurotoxicity in Dros...
  7. Reinwardtia indica Dumort. protects against ponatinib-induced cerebral ischemia in adult zebrafish via attenuation of oxidative stress, neuroinflammation, mitochondrial dysfunction, and neurotransmitter dysregulation: A multi-target therapeutic strategy
  8. Decoding chronic pain: insights into the transition from acute to persistent pain
  9. Unlocking the Therapeutic Potential of Piperine- From Ethnopharmacology to Nanodelivery Strategies
  10. Harnessing Nanoemulsions for Tailored Breast Cancer Therapy: Recent Insights and Opportunities
  11. Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions
  12. Decoding the neuroprotective potential of hesperidin: Insights into Alzheimer’s disease
  13. The Multifaceted Nature of Guggulsterone: Phytochemical Insights and Pharmacological Efficacy
  14. Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets
  15. Animal Models of Traumatic Brain Injury and Their Relevance in Clinical Settings
  16. Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
  17. Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer’s Disease
  18. Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders
  19. Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
  20. Diverse models in Alzheimer's research: exploring alternative approaches beyond traditional rodent frameworks
  21. Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic Implications
  22. Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases
  23. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
  24. Measuring dopamine in rodent brain tissue by using UHPLC-Xevo-TQD triple quadrupole mass spectrometry: A comparative influence of selegiline nanoemulsion administered intranasally over solution on upregulation of dopamine level
  25. Screening of surfactant mixture ratio for preparation of oil-in-water nanoemulsion: A technical note
  26. Unveiling Therapeutic Targets: Targeting Mitochondrial ROS for Anticancer Therapy
  27. Potential of nanoemulsions for accelerated wound healing: innovative strategies
  28. Insights on prospective role of Gallic acid as a Bioavailability Enhancer
  29. Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations
  30. Mechanistic Insights into the Pharmacological Significance of Silymarin
  31. New insights into quercetin nanoformulations for topical delivery
  32. Synthesis, Molecular Docking, and Biological Evaluation of Some Novel 2-(5-Substituted 1,3,4-oxadiazole-2-yl)-1,3-benzothiazole Derivatives as Anticonvulsant Agents
  33. Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus
  34. A review on liquid chromatographic methods for the bioanalysis of atorvastatin
  35. In-silico molecular docking study of some n-substituted thiazoles derivatives as FabH inhibitors
  36. Development and validation of HPLC-UV based bioanalytical method for the quantification of atorvastatin in rat plasma
  37. Molecular docking of some benzothiazoles derivatives as anticonvulsant agents